449 related articles for article (PubMed ID: 31495054)
1. Dissection of gastric cancer heterogeneity for precision oncology.
Ho SWT; Tan P
Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of gastric cancer.
Chia NY; Tan P
Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
Gullo I; Carneiro F; Oliveira C; Almeida GM
Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
[TBL] [Abstract][Full Text] [Related]
4. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.
Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357
[TBL] [Abstract][Full Text] [Related]
5. Mapping the genomic diaspora of gastric cancer.
Yeoh KG; Tan P
Nat Rev Cancer; 2022 Feb; 22(2):71-84. PubMed ID: 34702982
[TBL] [Abstract][Full Text] [Related]
6. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
[TBL] [Abstract][Full Text] [Related]
7. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
Front Immunol; 2022; 13():951137. PubMed ID: 35990657
[TBL] [Abstract][Full Text] [Related]
8. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
9. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer.
Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B
Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974
[TBL] [Abstract][Full Text] [Related]
10. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
Businello G; Galuppini F; Fassan M
Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
[TBL] [Abstract][Full Text] [Related]
11. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
Wu M; Wang Y; Liu H; Song J; Ding J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286
[TBL] [Abstract][Full Text] [Related]
13. Proposed Molecular and miRNA Classification of Gastric Cancer.
Alessandrini L; Manchi M; De Re V; Dolcetti R; Canzonieri V
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882766
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer and genomics: review of literature.
Onoyama T; Ishikawa S; Isomoto H
J Gastroenterol; 2022 Aug; 57(8):505-516. PubMed ID: 35751736
[TBL] [Abstract][Full Text] [Related]
15. A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.
Hu B; Sajid M; Lv R; Liu L; Sun C
Front Immunol; 2022; 13():996721. PubMed ID: 36389765
[TBL] [Abstract][Full Text] [Related]
16. Microarray and next-generation sequencing to analyse gastric cancer.
Dang Y; Wang YC; Huang QJ
Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic options opened by the molecular classification of gastric cancer.
Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539
[TBL] [Abstract][Full Text] [Related]
18. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
19. Dawn of precision medicine on gastric cancer.
Ishii T; Kawazoe A; Shitara K
Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
[TBL] [Abstract][Full Text] [Related]
20. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Choi YY; Cheong JH
Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
